Precision Biosciences DTIL
NASDAQ DTIL
$6.26 -0.07 (-1.03%)
As of: Oct 2, 2026 · 12:45 PM EDT

Precision Biosciences (DTIL) Cash from Financing Activities (2018 - 2026)

Updated

Precision Biosciences (DTIL) reported Cash from Financing Activities of $745,000 for fiscal Q1 2026 (quarter ended Mar 31, 2026), down 93.0% from $10.69 million a year earlier and down 99.0% from the prior quarter.

Analysis

Precision Biosciences (DTIL) Cash from Financing Activities (2018 - 2026) Analysis & Trends

For FY2025 (ended Dec 31, 2025), Precision Biosciences posted Cash from Financing Activities of $95.16 million, up 88.6% from FY2024.

  • Cash from Financing Activities has a five-year compound annual growth rate of 135.0% (FY2020 to FY2025).
  • By fiscal year, Cash from Financing Activities came in at $50.45 million in FY2024 (+836.5%), $5.39 million in FY2023 (-94.3%), $94.99 million in FY2022 (+34.7%) and $70.52 million in FY2021.
  • The fiscal Q1 2026 figure ranks as the lowest quarterly Cash from Financing Activities since fiscal Q2 2024.
  • Year over year, Cash from Financing Activities gained in two of the last six quarters, with growth averaging 80.0%.
  • The high point for year-over-year Cash from Financing Activities in five years was fiscal Q2 2025 (growth of 655.0%); the low point was fiscal Q2 2023 (a decline of 98.0%).
  • Per Business Quant data, the three fiscal quarters before Q1 2026 came in at $77.52 million (Q4 2025), $1.66 million (Q3 2025) and $5.3 million (Q2 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -8.78 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -5.05 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 1.76 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -2.02 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -47.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -1.48 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 2.34 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -3.66 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -426.70 Mn
10 Precision Biosciences 165.47 Mn -183.71 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 745,000.00
Dec 31, 2025 77.52 Mn
Sep 30, 2025 1.66 Mn
Jun 30, 2025 5.30 Mn
Mar 31, 2025 10.69 Mn
Dec 31, 2024 5.92 Mn
Sep 30, 2024 3.73 Mn
Jun 30, 2024 702,000.00
Mar 31, 2024 40.10 Mn
Dec 31, 2023 2.83 Mn
Sep 30, 2023 -34,000.00
Jun 30, 2023 1.85 Mn
Mar 31, 2023 741,000.00
Sep 30, 2022 -180,000.00
Jun 30, 2022 92.92 Mn
Mar 31, 2022 2.25 Mn
Dec 31, 2021 8.38 Mn
Sep 30, 2021 11.92 Mn
Jun 30, 2021 13.51 Mn
Mar 31, 2021 36.72 Mn
API Access

Precision Biosciences Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=DTIL&period=max&api_key=YOUR_API_KEY